Carson Wealth (CWM LLC)
NAMS icon

Carson Wealth (CWM LLC)’s NewAmsterdam Pharma NAMS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.6K Buy
1,018
+37
+4% +$1.21K ﹤0.01% 4101
2025
Q4 		$34K Buy
981
+2
+0.2% +$73 ﹤0.01% 3872
2025
Q3 		$28K Buy
979
+42
+4% +$1.01K ﹤0.01% 3924
2025
Q2 		$17K Buy
937
+817
+681% +$14.9K ﹤0.01% 4009
2025
Q1 		$2K Buy
120
+46
+62% +$1.02K ﹤0.01% 4786
2024
Q4 		$2K Buy
74
+36
+95% +$765 ﹤0.01% 4570
2024
Q3 		$1K Buy
+38
New +$657 ﹤0.01% 4639

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NAMS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its NewAmsterdam Pharma (NAMS) stake by 3.8% in Q1 2026, buying an estimated $1.21K and bringing the position to 1,018 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4101.

Carson Wealth (CWM LLC) first reported a position in NAMS in Q3 2024 and has held it in 7 quarters since. The position peaked at $34K in Q4 2025. 171 funds tracked by Wall St. Rank hold NAMS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,018 shares of NewAmsterdam Pharma worth $32.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 37 NewAmsterdam Pharma shares in Q1 2026, an estimated $1.21K.
  • NewAmsterdam Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4101 holding.
  • Carson Wealth (CWM LLC) first reported a position in NewAmsterdam Pharma in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s NewAmsterdam Pharma position peaked at $34K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.